Introduction of the Department
The Department of Neonatology, founded in 1998, was the first unattended neonatal ward in Xinjiang. It has altogether 22 beds available, in which 10 are in NICU (neonatal intensive care unit) and 12 in common neonatal ward. The department sets up 3 professional neonatal groups: intensive care group, non-infection group and infection group. There are 34 medical staffs, including 8 physicians and 26 nurses.
Now the Department of Neonatology has advanced diagnosis and treatment technologies, rich clinical experience in dealing with common and refractory neonatal diseases, and has made great achievements in the disease management of premature and low birth weight infants, neonatal hypoxic-ischemic encephalopathy, intracranial hemorrhage, neonatal shock, neonatal pneumorrhagia, especially in the treatment of multiple organ failure. It owns such breathing support technologies that more proper for newborns, including non-invasive ventilation, normal frequency ventilation, and high-frequency oscillating ventilation, and carries out vision and hearing screening as well as blood and urine screening for detecting congenital metabolic diseases among the newborns and contributes a lot to improving their survival rate and living quality.
Equipped with such advanced medical equipment as specialized neonatal breathing machine, electrocardiograph, open rescue treatment platform, infant incubator, blue-ray therapy box, and neonatal rescue and delivery box, the department creates better conditions for rescuing and treatment the newborns. It also provides dedicated pharmacy, nutrient solution preparation room, milk preparation room, and bath room for the newborns so as to guarantee the early recovery of those patients in a reliable way.


Introduction to the Experts


Name: Jiang Lan
Job title: Chief Physician

Specialty: diagnosis and treatment of difficult, refractory and critical neonatal diseases, especially proficient in non-invasive breathing ventilation, normal frequency mechanical ventilation, and high-frequency oscillating ventilation.



Name: Yang Yuexia
Job title: Associate Chief Physician
Specialty: neonatal resuscitation, neonatal care, and diagnosis and treatment of severe neonatal respiratory diseases.


Advanced instrument

Bedside cerebral function monitor
Bedside blood-gas analyzer IMG_0709
Open-type warming table IMG_0697
Blue-ray therapeutic instrument IMG_0702
Incubator IMG_0708
Horizontal non-invasive dual-breathing machine



Insomnia case

Case 1
The patient, a baby boy, was admitted due to “one day’s xanthochromia” 2 days after being born. He was discovered to have severe xanthochromia 7h after being born, and was transferred to our hospital due to limited medical conditions of local hospital.
The patient had an elder brother who died three days after birth with unknown cause. The patient’s mother had her second fetus die in the uterus without significant cause when being pregnant for 8 months, and received induced labor.
After being hospitalized, the patient accepted detailed examination which revealed he suffered from RH group incompatibility (anti-E hemolysis). Thus, the patient was offered blood transfusion and phototherapy to remove the jaundice, immune globulin to interdict hemolysis, albumin to promote combination of free bilirubin, anti-infection therapy, and anemia correction and so on, then his xanthochromia disappeared and was discharged.

Case 2
The patient, a baby girl, was admitted due to “polypnea and groan with cogwheel breathing for 6 hours” since being born.
The patient was the first fetus and first born of her mother with gestational age of 31+5W. She was born through cesarean delivery due to her mother’s “placental abruption” at the weight of 2,200g and 7 scores for Apgar grading, 9 scores after 5min through-mask positive pressure ventilation, and still 9 scores after 10min ventilation. The amniotic fluid was bloody.
Admitting diagnosis: respiratory distress syndrome of newborn, premature, low birth weight, and asphyxiated resuscitation. After being hospitalized, the patient was offered trachea cannula and mechanical ventilation for breathing support, IV dripping of ceftazidime to resist infection and ambroxol to promote pulmonary surfactant generation and enhance the airway management. The patient’s breathing support adopted horizontal noninvasive dual-breathing machine on the 5th day of treatment and single-nasal catheter on the 7th day. On the 13th day, the patient could leave the oxygen uptake. Through after treatment, the patient’s symptoms were stabilized and the respiratory distress syndrome was clinically cured.